APPLICATION
ANDA217227
TYPE
ANDA
ORIGINAL APPROVAL
2024-12-20
LATEST ACTION
2024-12-20
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
TETRACAINE HYDROCHLORIDEPrescription
TETRACAINE HYDROCHLORIDE 0.5% · SOLUTION · OPHTHALMIC
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.